NCT00167960View on ClinicalTrials.gov

Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit

CompletedOBSERVATIONAL
Enrollment

1,500

Participants

Timeline

Start Date

January 31, 2005

Conditions
Gram-Positive Bacterial Infections
Interventions
DRUG

Piperacillin/tazobactam and other β-lactam/β-lactamase

Trial Locations (2)

405-760

Incheon

682-714

Ulsan

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00167960 - Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit | Biotech Hunter | Biotech Hunter